Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
Launched by UNIVERSITY OF CALIFORNIA, DAVIS · Feb 2, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how eating beef as part of a heart-healthy diet might help the body absorb zinc better. Zinc is an important mineral that helps with many body functions, including heart health. The researchers believe that the way nutrients in beef work together could make zinc more effective when it gets into the cells. They are especially interested in older adults aged 55 to 70, as this group is more likely to have zinc deficiency and heart-related issues.
To participate in the study, you need to be a man or a postmenopausal woman between the ages of 55 and 70, and you should be in generally good health with a stable weight. Certain health conditions, like diabetes, high blood pressure, or heart disease, and specific dietary habits, like being vegan or consuming a lot of certain foods, may make you ineligible. If you join the trial, you will follow specific guidelines and may need to stop taking certain supplements for a while. The goal is to see if daily beef intake can positively affect your health by improving zinc levels in your body.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or postmenopausal female 55-70 years of age
- • Women: lack of menses for at least two years.
- • Subject is willing and able to comply with the study protocols.
- • Subject is willing to participate in all study procedures
- • Self-reported stable dose of prescribed medications for a minimum of 6 months
- • BMI 18.5 - 29.9 kg/m2
- Exclusion Criteria:
- • Self-reported use of daily anticoagulation agents including aspirin, NSAIDs
- • Prescribed metaformin, statins or medications known to interfere with zinc, protein, or lipid metabolism
- • Vegan, Vegetarians, food faddists or those consuming a non-traditional diet (e.g. Adkins, Keto, Paleo, etc.)
- • Fruit consumption ≥ 3 cups/day
- • Regular consumption of strawberries (2-3 servings/week)
- • Vegetable consumption ≥ 4 cups/day
- • Coffee/tea ≥ 3 cups/day
- • Dark chocolate ≥ 3 oz/day
- • Alcohol intake greater than 2 drinks in a day for men, or 1 drink in a day for women.
- • Self-reported restriction of physical activity due to a chronic health condition
- • Self-reported chronic/routine high intensity exercise
- • Self-reported diabetes
- • Blood pressure ≥ 140/90 mm Hg
- • Self-reported renal or liver disease
- • Self-reported heart disease, which includes cardiovascular events and stroke
- • Peripheral artery disease Raynaud's syndrome or disease
- • Inability to properly place or wear the PAT probes or abnormal measurements on pre-screening PAT
- • Self-reported cancer within past 5 years
- • Self-reported malabsorption
- • Unwillingness to stop any supplement use six weeks prior to study initiation, including multivitamin/mineral, powders, herbal, plant or botanical, pro- and prebiotics, and oil supplements.
- • Smoking, vaping, cannabis use
- • Current enrollee in a clinical research study.
About University Of California, Davis
The University of California, Davis (UC Davis) is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials and studies. With a strong focus on interdisciplinary collaboration, UC Davis leverages its extensive expertise in medical research, education, and patient care to drive breakthroughs in various fields, including medicine, public health, and agriculture. The university's clinical trial programs emphasize rigorous scientific methodology and ethical standards, aiming to translate research findings into impactful treatments and improved patient outcomes. Through its state-of-the-art facilities and a dedicated team of researchers and healthcare professionals, UC Davis is at the forefront of transforming healthcare practices and addressing critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Davis, California, United States
Patients applied
Trial Officials
Carl L Keen, PhD
Principal Investigator
Distinguished Professor Emeritus of Nutrition
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials